Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Helix Biopharma Corp T.HBP

Alternate Symbol(s):  HBPCF

Healthcare Biotechnology
Helix BioPharma Corp. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies in the field of immune oncology for the prevention and treatment of cancer based on its proprietary technological platform DOS47. DOS47 is a broad anti-cancer antibody drug conjugate (ADC) platform. DOS47 is based upon a naturally occurring enzyme isolated from the jack bean plant... see more

Recent & Breaking News (TSX:HBP)

Helix Biopharma Corp. Provides Polish Subsidiary Divestiture Update

Accesswire September 30, 2020

Helix BioPharma Corp. Provides Polish Subsidiary Divestiture Update

Accesswire August 31, 2020

Helix BioPharma Corp. and Moffitt Cancer Center Extend Immunotherapy Collaboration

Accesswire August 12, 2020

49 Public Companies to Present at the SNN Network Virtual Conference on August 3-6, 2020

Accesswire August 3, 2020

Helix BioPharma Corp. to Present at the SNN Network Virtual Conference

Accesswire July 31, 2020

Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results

GlobeNewswire July 30, 2020

Helix BioPharma Corp. to Present at Alpha Bronze Virtual Town Hall

Accesswire July 27, 2020

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

GlobeNewswire July 13, 2020

Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary

GlobeNewswire June 26, 2020

Proactive Virtual Event Showcases Four Rising Stars of the Life Sciences Industry

GlobeNewswire June 22, 2020

Helix BioPharma Corp. to Present at Proactive One2One Virtual Investor Forum

GlobeNewswire June 22, 2020

Helix BioPharma Corp. Provides Update On The Timing Of Filing Of Third Quarter Results

GlobeNewswire June 11, 2020

Helix BioPharma Corp. L-DOS47 Phase I Lung Cancer Trial Data to be released at ASCO 2020

GlobeNewswire May 14, 2020

Helix BioPharma Corp. Provides Corporate Update

GlobeNewswire April 2, 2020

HELIX BIOPHARMA CORP. ANNOUNCES FISCAL SECOND QUARTER 2020 RESULTS

GlobeNewswire March 16, 2020

Helix BioPharma Corp. Closes $6.0 Million Private Placement

GlobeNewswire March 12, 2020

Helix BioPharma Corp. to Present at the Noble Capital Markets' Sixteenth Annual Investor Conference

GlobeNewswire February 14, 2020

Helix BioPharma Corp. Closes $3.0 Million Private Placement

GlobeNewswire January 13, 2020

Helix BioPharma Corp. to Present at the Biotech Showcase Conference in San Francisco

GlobeNewswire January 8, 2020

Helix BioPharma Corp. Announces Fiscal First Quarter 2020 Results

GlobeNewswire December 13, 2019